Farrokh Alemi

2.2k total citations
132 papers, 1.6k citations indexed

About

Farrokh Alemi is a scholar working on General Health Professions, Epidemiology and Economics and Econometrics. According to data from OpenAlex, Farrokh Alemi has authored 132 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in General Health Professions, 25 papers in Epidemiology and 23 papers in Economics and Econometrics. Recurrent topics in Farrokh Alemi's work include Healthcare Policy and Management (18 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Substance Abuse Treatment and Outcomes (9 papers). Farrokh Alemi is often cited by papers focused on Healthcare Policy and Management (18 papers), Health Systems, Economic Evaluations, Quality of Life (11 papers) and Substance Abuse Treatment and Outcomes (9 papers). Farrokh Alemi collaborates with scholars based in United States, Canada and France. Farrokh Alemi's co-authors include Raya Kheirbek, Duncan Neuhauser, Janusz Wojtusiak, Richard C. Stephens, Mary R. Haack, Kenneth L. Cox, D J Savory, Michael Emch, Cari Levy and Shirley M. Moore and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Farrokh Alemi

124 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Farrokh Alemi United States 21 530 313 232 199 125 132 1.6k
Louise Preston United Kingdom 21 491 0.9× 244 0.8× 319 1.4× 127 0.6× 124 1.0× 54 1.5k
Richard Jacques United Kingdom 28 432 0.8× 239 0.8× 388 1.7× 259 1.3× 143 1.1× 96 2.8k
David M. Zucker Israel 31 316 0.6× 282 0.9× 299 1.3× 433 2.2× 113 0.9× 92 3.9k
Byron J. Gajewski United States 24 739 1.4× 213 0.7× 546 2.4× 212 1.1× 139 1.1× 153 2.2k
Alain Mayhew Canada 24 770 1.5× 422 1.3× 428 1.8× 257 1.3× 102 0.8× 48 2.6k
Marco Ghassemi Canada 19 568 1.1× 193 0.6× 253 1.1× 188 0.9× 230 1.8× 26 2.0k
Lisa Strifler Canada 13 513 1.0× 160 0.5× 333 1.4× 163 0.8× 143 1.1× 17 2.1k
Viet-Thi Tran France 22 387 0.7× 407 1.3× 241 1.0× 347 1.7× 260 2.1× 67 1.9k
Tanja Bekhuis United States 13 354 0.7× 147 0.5× 355 1.5× 84 0.4× 153 1.2× 26 1.9k
Karen Daniels United States 24 1.1k 2.0× 226 0.7× 348 1.5× 199 1.0× 171 1.4× 83 2.5k

Countries citing papers authored by Farrokh Alemi

Since Specialization
Citations

This map shows the geographic impact of Farrokh Alemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farrokh Alemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farrokh Alemi more than expected).

Fields of papers citing papers by Farrokh Alemi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farrokh Alemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farrokh Alemi. The network helps show where Farrokh Alemi may publish in the future.

Co-authorship network of co-authors of Farrokh Alemi

This figure shows the co-authorship network connecting the top 25 collaborators of Farrokh Alemi. A scholar is included among the top collaborators of Farrokh Alemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farrokh Alemi. Farrokh Alemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Min, Hua & Farrokh Alemi. (2025). Insights into prescribing patterns for antidepressants: an evidence-based analysis. BMC Medical Informatics and Decision Making. 25(1). 42–42.
2.
Min, Hua, Farrokh Alemi, & Janusz Wojtusiak. (2023). Selecting Antidepressants Based on Medical History and Stress Mechanism. Cureus. 15(4). e37117–e37117. 1 indexed citations
3.
Wojtusiak, Janusz, et al.. (2021). Using Wi-Fi Infrastructure to Predict Contacts During Pandemics. 347–356. 3 indexed citations
4.
Alemi, Farrokh, et al.. (2020). US veterans administration diabetes risk (VADR) national cohort: cohort profile. BMJ Open. 10(12). e039489–e039489. 19 indexed citations
5.
Davis, Phillip, Mengling Liu, Scott E. Sherman, et al.. (2018). HbA1c, lipid profiles and risk of incident type 2 Diabetes in United States Veterans. PLoS ONE. 13(9). e0203484–e0203484. 19 indexed citations
6.
Alemi, Farrokh, et al.. (2018). Electronic Health Record-Based Screening for Substance Abuse. Big Data. 6(3). 214–224. 2 indexed citations
7.
Fletcher, Ross D., H. J. Moore, Richard Amdur, et al.. (2017). GUIDELINES ALLOWING CONTROL OF HYPERTENSION IN NON-DIABETICS GREATER THAN 60 YEARS OLD AT UP TO 150 MMHG AVERAGE SYSTOLIC BLOOD PRESSURE INCREASES PATIENT MORTALITY IN VETERANS. Journal of the American College of Cardiology. 69(11). 1690–1690. 1 indexed citations
8.
Tuck, Matthew, et al.. (2017). A Comprehensive Index for Predicting Risk of Anemia from Patients' Diagnoses. Big Data. 5(1). 42–52. 6 indexed citations
9.
Alemi, Farrokh, Cari Levy, & Raya Kheirbek. (2016). The Multi-Morbidity Index: A Tool for Assessing the Prognosis of Patients from History of Illness. SHILAP Revista de lepidopterología. 4(1). 19–19. 14 indexed citations
10.
Kheirbek, Raya, et al.. (2013). Trajectory of Illness for Patients with Congestive Heart Failure. Journal of Palliative Medicine. 16(5). 478–484. 46 indexed citations
11.
Alemi, Farrokh, et al.. (2011). Genetic markers anticipate response to citalopram in a majority of patients. Psychiatric Genetics. 21(6). 287–293. 1 indexed citations
12.
Alemi, Farrokh, et al.. (2011). A Simple Method for Causal Analysis of Return on IT Investment. Journal of Healthcare Engineering. 2(1). 43–53. 1 indexed citations
13.
Alemi, Farrokh & Duncan Neuhauser. (2004). Time-Between Control Charts for Monitoring Asthma Attacks. PubMed. 30(2). 95–102. 29 indexed citations
14.
Alemi, Farrokh. (2004). Tukeyʼs Control Chart. Quality Management in Health Care. 13(4). 216–221. 42 indexed citations
15.
Alemi, Farrokh, et al.. (2002). Unit cost of counseling and patients length of stay in a residential drug treatment setting.. PubMed. 5(3). 103–7. 1 indexed citations
16.
Haack, Mary R. & Farrokh Alemi. (2002). Medicaid Reimbursement of Primary Care Providers for Treatment of Substance use Disorders. Substance Abuse. 23(1_suppl). 95–104. 1 indexed citations
17.
Glaser, John, et al.. (2000). Management Response to the E-Health Revolution / Reply from Joseph M. DeLuca & Rebecca Enmark / Reply from Farrokh Alemi. Frontiers of Health Services Management. 17(1). 45. 1 indexed citations
18.
Patrick, Kevin, et al.. (1999). Policy issues relevant to evaluation of interactive health communication applications. The Science Panel on Interactive Communication and Health.. PubMed. 16(1). 35–42. 14 indexed citations
19.
Alemi, Farrokh, et al.. (1996). Educating Patients at Home. Medical Care. 34(Supplement). 21–31. 19 indexed citations
20.
Alemi, Farrokh, et al.. (1987). A Computer Game to Teach Teenagers about Sexual Decision Making.. PubMed Central. 521–525.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026